Global Axicabtagene Ciloleucel Market, By Drug Class (Miscellaneous Antineoplastic, Other), Application (Large B-cell Lymphoma, Follicular Lymphoma, Other), Dosage (Suspension, Injection, Other), Route of Administration (Intravenous, Other), End-Users (Clinic, Hospital, Cancer Treatment Center, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Axicabtagene Ciloleucel Market
Global axicabtagene ciloleucel market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 12.60% in the above mentioned forecast period.
Axicabtagene ciloleucel is a chimeric antigen receptor T cell (CAR-T) therapy which is used for the treatment of relaxed or refractory large B-cell lymphoma, diffuse large B-cell lymphoma, primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma in adults. This immunotherapy medicine is produced by using patient’s white blood cells, which have been modified to recognize and attack the cancer cells. It is also known as Yescarta.
Rise in the prevalence of cancer diseases across the world, technological advancement for advanced treatment options, growing government initiatives, increasing focus of pharmaceutical industries, and rise in the number of T cell therapy are the factors that will expand the global axicabtagene ciloleucel market.
Rising R&D activities and ongoing clinical trials will provide beneficial opportunities for the global axicabtagene ciloleucel market in the forecast period of 2021-2028.
High cost of treatment, severe side effects of axicabtagene ciloleucel such as cytokine release syndrome, immunoglobulinemia, kidney failure, high or low blood pressure, rapid heart rate, allergic reactions, and hallucination are the factors that will hamper the market growth and will further challenge the global axicabtagene ciloleucel market in the forecast period mentioned above.
This axicabtagene ciloleucel market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global axicabtagene ciloleucel market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Axicabtagene Ciloleucel Market Scope and Market Size
The axicabtagene ciloleucel market is segmented on the basis of drug class, application, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the axicabtagene ciloleucel market is segmented into miscellaneous antineoplastic and other.
- On the basis of application, the axicabtagene ciloleucel market is segmented into large B-cell lymphoma, follicular lymphoma and other.
- On the basis of dosage, the axicabtagene ciloleucel market is segmented into suspension, injection, and other.
- On the basis of route of administration, the axicabtagene ciloleucel market is segmented into intravenous and other.
- On the basis of end-users, the axicabtagene ciloleucel market is segmented into clinic, hospital, cancer treatment center and others.
- The axicabtagene ciloleucel market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Global Axicabtagene Ciloleucel Market Country Level Analysis
Global axicabtagene ciloleucel market is analyzed, and market size information is provided by the country, drug class, application, dosage, route of administration, end-users, and distribution channel as referenced above.
The countries covered in the global axicabtagene ciloleucel market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the axicabtagene ciloleucel market due to the presence of major key players, development in the new treatment therapies, well-developed healthcare sector, and increasing awareness towards health in this region. Global axicabtagene ciloleucel market in the Asia-Pacific and Europe is expected to grow during the forecast period due to the extensive research and development activities, rising investment in the healthcare sector, and growing concentration of key healthcare and drug manufacturers for new treatment options.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global axicabtagene ciloleucel market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Axicabtagene Ciloleucel Market Share Analysis
Global axicabtagene ciloleucel market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global axicabtagene ciloleucel market.
The major players covered in the global axicabtagene ciloleucel market report are Gilead Sciences, Inc., and Kite Pharma Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-